NCT01327599View on ClinicalTrials.gov

Efficacy of Changing to DUOTRAV® From Prior Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Open-Angle GlaucomaOcular HypertensionPigment Dispersion Glaucoma
Interventions
DRUG

Travoprost 0.004%+Timolol 0.5% ophthalmic solution

Fixed dose combination topical ocular agent preserved with polyquaternium-1 (POLYQUAD)

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY